XANTINOL NICOTINATE, (S)-
UNII 5BW6T3CFFK

Substance Identification & Data

This profile provides standardized clinical and technical data for Xantinol Nicotinate, (s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5BW6T3CFFK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5BW6T3CFFK

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

XANTINOL NICOTINATE, (S)-

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C13H21N5O4.C6H5NO2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

GEPMAHVDJHFBJI-FVGYRXGTSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

24867449

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12n(C)c(=O)n(c(c2n(cn1)C[C@H](CN(CCO)C)O)=O)C.C(c1cnccc1)(=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Xantinol Nicotinate, (s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

XANTHINOL NIACINATE, (S)-

XANTHINOL NICOTINATE, (S)-

XANTINOL NICOTINATE, (S)-

Brand / Trade Names

ANGIOAMIN, (S)-

ANGIOMIN, (S)-

COMPLAMEX, (S)-

COMPLAMIN RETARD, (S)-

COMPLAMIN, (S)-

CONTAMEX, (S)-

LANDRINA 300, (S)-

SADAMINE, (S)-

STENALGIL, (S)-

TEONICOL, (S)-

VEDRIN, (S)-

XAVIN, (S)-

Systematic Nomenclature

1H-PURINE-2,6-DIONE, 3,7-DIHYDRO-7-(2-HYDROXY-3-((2-HYDROXYETHYL)METHYLAMINO)PROPYL)-1,3-DIMETHYL-, MONO-3-PYRIDINECARBOXYLATE (SALT), (S)-

SYS

3-PYRIDINECARBOXYLIC ACID, COMPD. WITH 3,7-DIHYDRO-7-(2-HYDROXY-3-((2-HYDROXYETHYL)METHYLAMINO)PROPYL)-1,3-DIMETHYL-1H-PURINE-2,6-DIONE (1:1), (S)-

SYS

7-(2-HYDROXY-3-((2-HYDROXYETHYL)METHYLAMINO)PROPYL)THEOPHYLLINE NICOTINATE, (S)-

SYS

7-(2-HYDROXY-3-(N-(2-HYDROXYETHYL)-N-METHYLAMINO)PROPYL)-1,3-DIMETHYLXANTHINE PYRIDINE-3-CARBOXYLATE, (S)-

SYS

7-(2-HYDROXY-3-(N-METHYL-N-(2-HYDROXYETHYL)AMINO)-PROPYL)-THEOPHYLLINE NICOTINATE, (S)-

SYS

7-(3-(METHYL-2-HYDROXYETHYLAMINO)-2-HYDROXYPROPYL))THEOPHYLLINE NICOTINATE, (S)-

SYS

NICOTINIC ACID, COMPD. WITH 7-(2-HYDROXY-3-((2-HYDROXYETHYL)METHYLAMINO)PROPYL)THEOPHYLLINE (1:1), (S)-

SYS

THEOPHYLLINE, 7-(2-HYDROXY-3-((2-HYDROXYETHYL)METHYLAMINO)PROPYL)-, MONONICOTINATE (SALT), (S)-

SYS

THEOPHYLLINE, 7-(2-HYDROXY-3-((2-HYDROXYETHYL)METHYLAMINO)PROPYL)-, NICOTINATE, (S)-

SYS

Technical Codes

NSC-113217, (S)-

SK-331A, (S)-

External Clinical & Regulatory Resources

Previous UNII5BV6T1107J

Next UNII5BWD2J7B4W